Jasper Therapeutics announces special shareholder meeting

• Jasper Therapeutics will hold a virtual special stockholder meeting on Sept. 30, 2026.
• Shareholders will vote on a potential reverse stock split, with the board authorized to set a ratio from 1-for-15 to 1-for-35.
• A separate proposal seeks to raise authorized common shares to 675,000,000 from 490,000,000.
• The agenda also includes a possible meeting adjournment to seek additional support for the reverse split or share authorization increase.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jasper Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-097572), on September 04, 2026, and is solely responsible for the information contained therein.